Bad Blood: Secrets and Lies in a Silicon Valley Startup

Bad Blood is an investigative account of Theranos, the failed blood-testing startup that became one of Silicon Valley's biggest scandals. Wall Street Journal reporter John Carreyrou chronicles the company's founding by Elizabeth Holmes through its rise to a $9 billion valuation and subsequent downfall. The book details how Theranos claimed to revolutionize blood testing with technology that could run hundreds of tests using just a few drops of blood. Through interviews with former employees and extensive research, Carreyrou reconstructs the internal workings of a company that attracted major investors and partnerships while hiding fundamental problems with its technology. The narrative follows the mounting pressure within Theranos as employees grappled with ethical concerns, technical failures, and a culture of secrecy enforced by its leadership. The investigation that ultimately exposed the truth involved corporate intimidation, legal threats, and whistleblowers who risked their careers to come forward. This work raises essential questions about innovation, ethics, and accountability in the startup world, where the drive for disruption can sometimes override scientific integrity and patient safety. The story stands as a cautionary tale about the dangers of Silicon Valley's "fake it till you make it" culture when applied to healthcare.

Readers called the book a detailed exposé that reads like a thriller, with clear explanations of complex medical and technical concepts. Many noted they couldn't put it down and finished it in one or two sittings. Readers appreciated: - Thorough investigative journalism and fact-checking - Clear timeline of events - Balanced reporting without sensationalism - Technical concepts explained for general audiences - Complex cast of characters tracked effectively Common criticisms: - Some repetition in later chapters - Too much detail about minor players - A few readers wanted more analysis of Silicon Valley culture - Some found the writing style dry Ratings: Goodreads: 4.4/5 (731,000+ ratings) Amazon: 4.7/5 (28,000+ ratings) Book of the Month Club: 4.5/5 Reader quote: "Like watching a train wreck in slow motion. Carreyrou's reporting lets you witness each small decision that led to the eventual collapse." - Goodreads reviewer

American Kingpin by Nick Bilton The story chronicles Ross Ulbricht's creation and operation of the Silk Road, a billion-dollar criminal empire built through technology and deception.

Empire of Pain by Patrick Radden Keefe This investigation uncovers the Sackler family's role in the opioid crisis through their company Purdue Pharma and its marketing of OxyContin.

Super Pumped: The Battle for Uber by Mike Isaac The book reveals the inner workings of Uber's rise and the downfall of its founder Travis Kalanick through corporate espionage, deception, and toxic culture.

Billion Dollar Loser by Reeves Wiedeman The rise and fall of WeWork's Adam Neumann shows how venture capital, charisma, and Silicon Valley's growth-at-all-costs mentality created a $47 billion valuation built on sand.

Billion Dollar Whale by Tom Wright The book follows Jho Low's execution of a $5 billion financial fraud through Malaysia's 1MDB fund, demonstrating how one man deceived banks, Hollywood, and governments.

🔍 The author spent over 3 years investigating Theranos, conducting more than 150 interviews with former employees, investors, and patients. 💉 Elizabeth Holmes deliberately lowered her voice by several octaves and wore black turtlenecks to emulate Steve Jobs, whom she considered a role model. 💰 At its peak in 2014, Theranos was valued at $9 billion, making Holmes the youngest self-made female billionaire in history at age 30. 🏢 The book inspired an ABC podcast ("The Dropout"), a Hulu series starring Amanda Seyfried, and an HBO documentary ("The Inventor"). ⚖️ Carreyrou's reporting in The Wall Street Journal led to multiple federal investigations, resulting in the company's dissolution and Holmes' eventual conviction on four counts of fraud in 2022.